Enhance reproducibility, comparability, and reliability in cell therapy development
Bringing cell & gene therapy from breakthrough science to reliable clinical manufacturing demands more than innovation—it requires analytical rigor and process discipline. Yet with complex biology, evolving regulatory expectations, and accelerating development timelines, many programs face the same challenge: how to scale confidently without sacrificing consistency, quality or speed.
Watch this expert led discussion from Citeline and Thermo Fisher Scientific as they share real-world strategies for building analytical strength early, standardizing critical assays, and leveraging scalable platforms to reduce uncertainty and accelerate translation. Learn how integrated analytical approaches are helping leading CGT programs move faster, make better decisions, and reach patients with greater confidence.
Gain insights into:
- Key analytical & bioprocess challenges in translating CGT's from research to manufacturing
- Practical approaches to assay standardization for data comparability & integrity
- How qPCR and dPCR are powering characterization & release testing
- Strategies for integrating analytical insights into scalable bioprocess development
Meet the Speakers
Sergio Ita, PhD
Manager, Patheon Translational Services
Thermo Fisher Scientific
Allison Kifer, MS
Scientist, Patheon Translational Services
Thermo Fisher Scientific

Inspire. Connect. Innovate.